ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,700Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 19

$606K Total Retail Price of All Prescriptions

Rank: 9 out of 19

123 Patients Receiving at Least One Drug in Part D
100%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 123 patients filled at least one prescription for a schedule two drug, compared to an average of 11%.

Schedule Three
Controlled Substances

15% of this provider’s 123 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

0% of this provider’s 10,700 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

87 is the average number of prescriptions (including refills) per patient, compared to an average of 36.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
WARFARIN SODIUM 1,079 1,079 1 1
FUROSEMIDE 382 382 2 2
CITALOPRAM HBR 380 380 3 13
OMEPRAZOLE 330 330 4 14
LISINOPRIL 294 294 5 7
AMLODIPINE BESYLATE 279 279 6 6
LEVOTHYROXINE SODIUM 279 279 6 3
NAMENDA 252 252 8 4
METOPROLOL TARTRATE 244 244 9 5
DONEPEZIL HCL 243 243 10 9
POTASSIUM CHLORIDE 211 211 11 11
NOVOLOG FLEXPEN 209 209 12 44
HYDROCHLOROTHIAZIDE 206 206 13 32
MIRTAZAPINE 200 200 14 17
ADVAIR DISKUS 182 182 15 68
TRAZODONE HCL 179 179 16 24
RANITIDINE HCL 173 173 17 21
GABAPENTIN 148 148 18 10
LANTUS SOLOSTAR 147 147 19 69
TRAMADOL HCL 142 142 20 23
SIMVASTATIN 140 140 21 15
NEXIUM 138 138 22 43
IPRATROPIUM-ALBUTEROL 136 136 23 31
CEFTRIAXONE 120 120 24 87
RISPERIDONE 104 104 25 27
CARVEDILOL 102 102 26 22
KLOR-CON 10 97 97 27 53
LEVOFLOXACIN 95 95 28 52
PREDNISONE 92 92 29 28
SERTRALINE HCL 89 89 30 18
PRAVASTATIN SODIUM 87 87 31 25
LIDOCAINE HCL 87 87 31 102
XOPENEX 80 80 10 33 143
DIGOXIN 80 80 33 47
ROPINIROLE HCL 79 79 35 88
HYDRALAZINE HCL 76 76 36 66
SPS 74 74 37 134
ONDANSETRON HCL 74 74 37 144
QUETIAPINE FUMARATE 69 69 39 30
METFORMIN HCL 67 67 40 20
CLOPIDOGREL 64 64 41 38
SULFAMETHOXAZOLE-TRIMETHOPRIM 62 62 42 62
RESTASIS 61 61 43 112
HYDROCODONE-ACETAMINOPHEN 61 61 S3 43 8
LACTULOSE 59 59 45 119
ATORVASTATIN CALCIUM 59 59 45 33
ALBUTEROL SULFATE 58 58 47 45
ESCITALOPRAM OXALATE 54 54 48 12
FAMOTIDINE 54 54 48 36
SPIRIVA 53 53 50 98
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 23, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.